2.30pm – 4pm BST, 17 September 2025 ‐ 1 hour 30 mins
Room: Room 1B
Specialist Society
Session Title: Mimics in Sarcoma
Session Description: Join us for an interactive session looking at the diagnostic challenges in orthopaedic oncology as we explore bone and soft tissue lesions mistaken as benign conditions. We look specifically at the differentials of infection vs Ewings sarcoma and also haematoma / vascular lesions vs soft tissue sarcomas. Clinical presentation can be widely variable, often with vague symptoms and radiological interpretation of the imaging remains challenging with many differential diagnoses.
Session Chair: Lee Bayliss

Consultant Orthopaedic Surgeon, Royal National Orthopaedic Hospital, Stanmore


Consultant Sarcoma and Reconstruction Surgeon, Royal National Orthopaedic Hospital
Prof Lee Jeys is an Orthopaedic surgeon specialising in Orthopaedic Oncology and complex lower limb arthroplasty including periprosthetic joint infection from Birmingham, UK. He is clinical lead of the Oncology & Complex Arthroplasty unit at the Royal Orthopaedic Hospital, honorary Professor of Life and Health Sciences at Aston University and president elect of the British Orthopaedic Oncology Society.
He went to medical school at Liverpool University, completed his training in Yorkshire before undertaking an Arthroplasty fellowship at Wrightington Hospital, Oncology fellowship at the ROH and a BOA travelling fellowship, visiting several units in Malaysia, Hong Kong, Australia and Europe. He obtained a MSc in Orthopaedic Engineering and a DSc with his thesis ‘Improving Patient Outcomes by Innovation and Collaboration in Orthopaedic Oncology & Complex Arthroplasty’. He has over 300 publications on oncology, arthroplasty, infection and basic science. He is a Board Member of International Society of Limb Salvage and has been a former Chair of National Cancer Research Institute Sarcoma Clinical Studies Group and board member of European Society of Musculoskeletal Oncology. He lectures internationally on both Oncology and Arthroplasty, a visiting Professor in many units and has on average published a paper per month since being appointed as a consultant.
He recently organised a global consensus meeting in controversial aspects of Orthopaedic Oncology to wide acclaim. He lives on a farm in rural Worcestershire with his partner and young daughter, whilst his 3 grown up children study Law, Engineering and Philosophy at university. Once a decent high jumper, water polo player and marathon runner, he now mainly contemplates his growing navel but can be stirred into sporting action occasionally.

Consultant Orthopaedic Surgeon, Royal National Orthopaedic Hospital, Stanmore
Hel is a Consultant Orthopaedic Sarcoma Surgeon practising at the Royal National Orthopaedic Hospital, Stanmore. She is a member of the London Sarcoma Service and specialises in primary bone and soft tissue sarcomas, benign tumours and metastatic disease. Her focus is to provide a patient-centred approach incorporating shared decision making with specialist experience to achieve the best outcomes for her patients. She works closely with her oncology colleagues as well as other surgical specialties to ensure that her patients benefit from a full multidisciplinary team.
Mr. Vineet Kurisunkal is a Consultant Orthopaedic Oncologist at the Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, one of Europe’s foremost centres for bone and soft tissue tumour management. His clinical practice is dedicated to the treatment of benign and malignant bone and soft tissue tumours (sarcomas) as well as metastatic bone disease. He is highly experienced in performing complex Sacro-pelvic and extremity resections and reconstructions, including the use of advanced navigation-assisted techniques for pelvic and sacral tumour surgery.
Mr. Kurisunkal graduated with his medical degree and completed his postgraduate training in orthopaedic surgery in India. He went on to pursue advanced subspecialty fellowship training in orthopaedic oncology at the world-renowned Tata Memorial Centre in Mumbai, one of the largest sarcoma referral centres globally, under the mentorship of Professor Ajay Puri and Professor Ashish Gulia. He subsequently refined his expertise in computer-assisted and navigation-guided tumour resections during his fellowship at the Royal Orthopaedic Hospital, Birmingham, under Professor Lee Jeys, in a program certified by the Royal College of Surgeons of England.
In addition to his clinical practice, Mr. Kurisunkal is an active academic with a strong portfolio of peer-reviewed publications in leading international orthopaedic and oncology journals. He has authored book chapters on sarcoma management in authoritative textbooks and continues to contribute to advancing surgical techniques and oncological outcomes through his research. His areas of academic interest include limb salvage surgery, pelvic and sacral tumour resections, endoprosthetic reconstructions, and navigation-assisted orthopaedic oncology.
He is a regular presenter at national and international meetings, where his work on complex tumour resections, reconstructions, and innovative surgical approaches has been recognised and widely cited. Beyond his clinical and academic contributions, Mr. Kurisunkal is deeply committed to multidisciplinary collaboration and education, with a focus on improving patient outcomes and advancing global standards in sarcoma care.

Consultant Sarcoma and Reconstruction Surgeon, Royal National Orthopaedic Hospital
Lee is a consultant sarcoma and reconstruction surgeon at the Royal National Orthopaedic Hospital, specialising in adult and paediatric musculoskeletal tumours. Having graduated from Imperial College School of Medicine, he underwent training in Oxford before completing a fellowship in bone and soft tissue sarcoma reconstruction at RNOH, Stanmore and was appointed as a Consultant there in 2019.
He is currently data and genomics lead for the London Sarcoma Service and has received awards from the Bone Cancer Research Trust, International Society of Orthopaedic Centres, University of Oxford and the British Orthopaedic Oncology Society (BOOS) for his work. He is a member of the BOOM consensus group and a current board member of BOOS.